Format

Send to

Choose Destination
Nat Rev Drug Discov. 2010 Feb;9(2):129-40. doi: 10.1038/nrd2958. Epub 2010 Jan 22.

Strategies for treating idiopathic pulmonary fibrosis.

Author information

1
National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, USA. duboisr@njhealth.org

Abstract

Idiopathic pulmonary fibrosis (IPF) is the most common and most lethal diffuse fibrosing lung disease, with a mortality rate that exceeds that of many cancers. Recently, there have been many clinical trials of novel therapies for IPF. The results have mostly been disappointing, although two treatment approaches have shown some efficacy. This Review describes the difficulties of treating IPF and the approaches that have been tried or are in development, and concludes with suggestions of future therapeutic targets and strategies.

PMID:
20094055
DOI:
10.1038/nrd2958
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center